FLOXIM-200 Tablet

ក្រុមហ៊ុនផលិតឱសថ:

 

Florencia Healthcare, India

ក្រុមហ៊ុនចែកចាយឱសថនៅប្រទេសកម្ពុជា:

 

SAKCAM PHARMA CO., LTD.

  • សារធាតុសកម្ម
  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់
  • ហាមប្រើ
  • ផលរំខាន
  • អន្តរប្រតិកម្ម
  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន
  • ការប្រុងប្រយ័ត្នជាពិសេស
  • បរិយាយប័ណ្ណឱសថ 
  • សារធាតុសកម្ម

    Each film-coated tablet contains:

    Cefixime 200mg

  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់

    INDICATIONS:

    FLOXIM is indicated in the treatment of the following infections caused by susceptible organisms

    1. Urinary tract infections

    2. Upper and lower respiratory tract infections

    3. Acute otitis media.

    4. Gonococcal urethritis

    5. Typhoid.

    DOSAGE AND DIRECTION FOR USE:

    FLOXIM by oral administration

    The usual adult of Cefixime (anhydrous) is 200-400mg per day administered orally, either as a single dose or in two divided doses, although lower doses may prove sufficient to treat uncomplicated urinary tract infections.

    For children: 8mg/kg daily, as either a single dose or in two divided doses, is recommended. In uncomplicated gonococcal urethritis, a single oral dose of 400mg has been found to be effective. Or as directed by the physician.

  • ហាមប្រើ

    Cefixime is contraindicated in patients with known sensitivity or allergies to cephalosporin class of antibiotics. As cefixime is third generation cephalosporin, it is not contraindicated for patients with a true penicillin allergy.

  • ផលរំខាន

    Cefixime is generally well tolerated. Majority of adverse reactions in clinical trials were mild and self-limiting in nature.

    The most frequent side effects seen with cefixime are diarrhoea and stool changes, diarrhoea has been more commonly associated with higher doses. Some cases of moderate to severe diarrhoea have been reported, this has occasionally warranted cessation of therapy. Other side effects include headache and dizziness. Mild transient changes in liver and renal function test have been observed. Allergies in the form of rash pruritus, urticaria, drug fever and arthralgia have been observed.

  • អន្តរប្រតិកម្ម

    In common with other cephalosporins, increase in prothrombin times has been noted in a few patients. Care should therefore be taken in patients receiving anticoagulation therapy.

  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន

    FLOXIM should not be used in pregnancy or in nursing mothers unless considered essential by the physician.

  • ការប្រុងប្រយ័ត្នជាពិសេស

    The possibility of the emergence of resistant organism which might result in overgrowth should be kept in mind, particularly during prolonged treatment.

    FLOXIM should be used with caution in patients with marked renal impairment.

*ព័ត៌មានឱសថត្រូវបានរៀបរៀងដោយ អ៊ីម៉ាតុគឹ មេឌីក (ខេមបូឌា) ដោយផ្អែកលើប្រភពព័ត៌មានខាងក្រោម។ សម្រាប់ព័ត៌មានលម្អិត សូមស្វែងរកនៅក្នុងក្រដាសព័ត៌មាននៃឱសថនីមួយៗ ឬ សាកសួរទៅកាន់ក្រុមហ៊ុនឱសថឬតំណាងចែកចាយនៃឱសថនីមួយៗ។

ប្រភពព័ត៌មាន៖

- ក្រដាសព័ត៌មាននៃឱសថសម្រាប់អ្នកជំនាញវេជ្ជសាស្ត្រដែលប្រើប្រាស់នៅប្រទេសជប៉ុន (Pharmaceutical and Medical Devices Agency, Pmda): https://www.pmda.go.jp

- ព័ត៌មានសង្ខេបនៃឱសថសម្រាប់អ្នកជំងឺដែលប្រើប្រាស់នៅប្រទេសជប៉ុន: http://www.rad-ar.or.jp